Furthermore, Kaplan-Meier survival analysis demonstrated significant associations of positive GRP94 expression with poor relapse-free survival (RFS) and distant-metastasis-free survival (DMSF) outcomes in breast cancer patients (p < 0.001; Fig. 1c). Here, HSP90B1 is linked to breast carcinoma.